Proteomic analysis of 1α,25-Dihydroxyvitamin D 3 action on human colon cancer cells reveals a link to splicing regulation

Journal of Proteomics

Volumn 75, Issue 2, 2011, Pages 384-397

  Cristobo, Iván ^a   Larriba, María Jesús ^b,c   Ríos, Vivian de los ^a   García, Francisco ^a   Muñoz, Alberto ^b,c   Casal, J Ignacio ^a  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^b INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

Author keywords

2D DIGE; Colon cancer; Nuclear proteins; Spliceosome; Vitamin D

Indexed keywords

CALCITRIOL; CYTOSKELETON PROTEIN; NUCLEAR PROTEIN; RNA;

ARTICLE; CANCER CELL; CELL ADHESION; CELLULAR DISTRIBUTION; COLON CANCER; DRUG MECHANISM; HUMAN; HUMAN CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEOMICS; RNA PROCESSING; SPLICEOSOME;

CALCITRIOL; CELL LINE, TUMOR; COLONIC NEOPLASMS; CYTOSKELETAL PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PROTEOMICS; RNA SPLICING; SPLICEOSOMES; TWO-DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

EID: 82355173271     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2011.08.003     Document Type: Article

References (53)

1. Gorham E.D., Garland C.F., Garland F.C., Grant W.B., Mohr S.B., Lipkin M., et al. Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. Am J Prev Med 2007, 32:210-216.
2. Yin L., Grandi N., Raum E., Haug U., Arndt V., Brenner H. Meta-analysis: longitudinal studies of serum vitamin D and colorectal cancer risk. Aliment Pharmacol Ther 2009, 30:113-125.
3. Giovannucci E. Epidemiology of vitamin D and colorectal cancer: casual or causal link?. J Steroid Biochem Mol Biol 2010, 121:349-354.
4. Mezawa H., Sugiura T., Watanabe M., Norizoe C., Takahashi D., Shimojima A., et al. Serum vitamin D levels and survival of patients with colorectal cancer: post-hoc analysis of a prospective cohort study. BMC Cancer 2010, 10:347.
5. Ordóñez-Morán P., Larriba M.J., Pendás-Franco N., Aguilera O., González-Sancho J.M., Muñoz A. Vitamin D and cancer: an update of in vitro and in vivo data. Front Biosci 2005, 10:2723-2749.
6. Eelen G., Gysemans C., Verlinden L., Vanoirbeek E., De Clercq P., Van Haver D., et al. Mechanism and potential of the growth-inhibitory actions of vitamin D and analogs. Curr Med Chem 2007, 14:1893-1910.
7. Deeb K.K., Trump D.L., Johnson C.S. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer 2007, 7:684-700.
8. Plum L.A., DeLuca H.F. Vitamin D, disease and therapeutic opportunities. Nat Rev Drug Discov 2010, 9:941-955.
9. Lappe J.M., Travers-Gustafson D., Davies K.M., Recker R.R., Heaney R.P. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007, 85:1586-1591.
10. 3 promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of β-catenin signaling. J Cell Biol 2001, 154:369-387.
11. Pálmer H.G., Sanchez-Carbayo M., Ordóñez-Morán P., Larriba M.J., Cordon-Cardo C., Muñoz A. Genetic signatures of differentiation induced by 1alpha,25-dihydroxyvitamin D3 in human colon cancer cells. Cancer Res 2003, 63:7799-7806.
12. Aguilera O., Peña C., García J.M., Larriba M.J., Ordóñez-Morán P., Navarro D., et al. The Wnt antagonist DICKKOPF-1 gene is induced by 1alpha,25-dihydroxyvitamin D3 associated to the differentiation of human colon cancer cells. Carcinogenesis 2007, 28:1877-1884.
13. Álvarez-Díaz S., Valle N., García J.M., Peña C., Freije J.M., Quesada V., et al. Cystatin D is a candidate tumor suppressor gene induced by vitamin D in human colon cancer cells. J Clin Invest 2009, 119:2343-2358.
14. Barbachano A., Ordóñez-Morán P., García J.M., Sánchez A., Pereira F., Larriba M.J., et al. SPROUTY-2 and E-cadherin regulate reciprocally and dictate colon cancer cell tumourigenicity. Oncogene 2010, 29:4800-4813.
15. 3 and its analog EB1089 under growth-inhibitory conditions in squamous carcinoma cells. Mol Endocrinol 2001, 15:1127-1139.
16. 3 in primary cultures of human prostatic epithelial cells revealed by cDNA microarray analysis. J Steroid Biochem Mol Biol 2004, 92:131-141.
17. 3 revealed by microarray analysis. J Biol Chem 2005, 280:35458-35468.
18. Miura K., Fujibuchi W., Sasaki I. Alternative pre-mRNA splicing in digestive tract malignancy. Cancer Sci 2011, 102:309-316.
19. David C.J., Manley J.L. Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged. Genes Dev 2011, 24:2343-2364.
20. Wessel D., Flugge U.I. A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Anal Biochem 1984, 138:141-143.
21. Larriba M.J., Casado-Vela J., Pendás-Franco N., Pena R. García de Herreros A, Berciano MT, et al. Novel snail1 target proteins in human colon cancer identified by proteomic analysis. PLoS One 2010, 5:e10221.
22. Alfonso P., Cañamero M., Fernandez-Carbonie F., Núñez A., Casal J.I. Proteome analysis of membrane fractions in colorectal carcinomas by using 2D-DIGE saturation labeling. J Proteome Res 2008, 7:4247-4255.
23. Alfonso P., Nuñez A., Madoz-Gurpide J., Lombardía L., Sánchez L., Casal J.I. Proteomic expression analysis of colorectal cancer by two-dimensional differential gel electrophoresis. Proteomics 2005, 5:2602-2611.
24. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
25. Dennis G., Sherman B.T., Hosack D.A., Yang J., Gao W., Lane H.C., et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003, 4:P3.
26. Huang da W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4:44-57.
27. Jensen L.J., Kuhn M., Stark M., Chaffron S., Creevey C., Muller J., et al. STRING 8-a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res 2009, 37:D412-D416.
28. Hoffmann R., Valencia A. A gene network for navigating the literature. Nat Genet 2004, 36:664.
29. Kanehisa M., Araki M., Goto S., Hattori M., Hirakawa M., Itoh M., et al. KEGG for linking genomes to life and the environment. Nucleic Acids Res 2008, 36:D480-D484.
30. Di Cristofano C., Leopizzi M., Miraglia A., Sardella B., Moretti V., Ferrara A., et al. Phosphorylated ezrin is located in the nucleus of the osteosarcoma cell. Mod Pathol 2010, 23:1012-1020.
31. Ordóñez-Morán P., Larriba M.J., Pálmer H.G., Valero R.A., Barbachano A., Dunach M., et al. RhoA-ROCK and p38MAPK-MSK1 mediate vitamin D effects on gene expression, phenotype, and Wnt pathway in colon cancer cells. J Cell Biol 2008, 183:697-710.
32. Andersen J.S., Lyon C.E., Fox A.H., Leung A.K., Lam Y.W., Steen H., et al. Directed proteomic analysis of the human nucleolus. Curr Biol 2002, 12:1-11.
33. Patton J.G., Porro E.B., Galceran J., Tempst P., Nadal-Ginard B. Cloning and characterization of PSF, a novel pre-mRNA splicing factor. Genes Dev 1993, 7:393-406.
34. Min H., Turck C.W., Nikolic J.M., Black D.L. A new regulatory protein, KSRP, mediates exon inclusion through an intronic splicing enhancer. Genes Dev 1997, 11:1023-1036.
35. Rappsilber J., Ryder U., Lamond A.I., Mann M. Large-scale proteomic analysis of the human spliceosome. Genome Res 2002, 12:1231-1245.
36. Ji Y., Tulin A.V. Poly(ADP-ribosyl)ation of heterogeneous nuclear ribonucleoproteins modulates splicing. Nucleic Acids Res 2009, 37:3501-3513.
37. Bentley D. The mRNA assembly line: transcription and processing machines in the same factory. Curr Opin Cell Biol 2002, 14:336-342.
38. Hall M.P., Huang S., Black D.L. Differentiation-induced colocalization of the KH-type splicing regulatory protein with polypyrimidine tract binding protein and the c-src pre-mRNA. Mol Biol Cell 2004, 15:774-786.
39. Trabucchi M., Briata P., Garcia-Mayoral M., Haase A.D., Filipowicz W., Ramos A., et al. The RNA-binding protein KSRP promotes the biogenesis of a subset of microRNAs. Nature 2009, 459:1010-1014.
40. Gherzi R., Trabucchi M., Ponassi M., Ruggiero T., Corte G., Moroni C., et al. The RNA-binding protein KSRP promotes decay of beta-catenin mRNA and is inactivated by PI3K-AKT signaling. PLoS Biol 2006, 5:e5.
41. Buratti E., Baralle F.E. The multiple roles of TDP-43 in pre-mRNA processing and gene expression regulation. RNA Biol 2010, 7:420-429.
42. Ramagopalan S.V., Heger A., Berlanga A.J., Maugeri N.J., Lincoln M.R., Burrell A., et al. A ChIP-seq defined genome-wide map of vitamin D receptor binding: Associations with disease and evolution. Genome Res 2010, 20:1352-1360.
43. Pokutta S., Weis W.I. The cytoplasmic face of cell contact sites. Curr Opin Struct Biol 2002, 12:255-262.
44. Kouchi Z., Fujiwara Y., Yamaguchi H., Nakamura Y., Fukami K. Phosphatidylinositol 5-phosphate 4-kinase type II beta is required for vitamin D receptor-dependent E-cadherin expression in SW480 cells. Biochem Biophys Res Commun 2011, 408:523-529.
45. Trinkle-Mulcahy L., Sleeman J.E., Lamond A.I. Dynamic targeting of protein phosphatase 1 within the nuclei of living mammalian cells. J Cell Sci 2001, 114:4219-4228.
46. Samarin S.N., Koch S., Ivanov A.I., Parkos C.A., Nusrat A. Coronin 1C negatively regulates cell-matrix adhesion and motility of intestinal epithelial cells. Biochem Biophys Res Commun 2010, 391:394-400.
47. Peinado H., Olmeda D., Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?. Nat Rev Cancer 2007, 7:415-428.
48. Kalluri R., Weinberg R.A. The basics of epithelial-mesenchymal transition. J Clin Invest 2009, 119:1420-1428.
49. Larriba M.J., Martin-Villar E., García J.M., Pereira F., Pena C., de Herreros A.G., et al. Snail2 cooperates with Snail1 in the repression of vitamin D receptor in colon cancer. Carcinogenesis 2009, 30:1459-1468.
50. Pálmer H.G., Larriba M.J., Garcia J.M., Ordóñez-Morán P., Pena C., Peiro S., et al. The transcription factor SNAIL represses vitamin D receptor expression and responsiveness in human colon cancer. Nat Med 2004, 10:917-919.
51. Hidalgo-Curtis C., Chase A., Drachenberg M., Roberts M.W., Finkelstein J.Z., Mould S., et al. The t(1;9)(p34;q34) and t(8;12)(p11;q15) fuse pre-mRNA processing proteins SFPQ (PSF) and CPSF6 to ABL and FGFR1. Genes Chromosomes Cancer 2008, 47:379-385.
52. Bond C.S., Fox A.H. Paraspeckles: nuclear bodies built on long noncoding RNA. J Cell Biol 2009, 186:637-644.
53. Rajesh C., Gruver A.M., Basrur V., Pittman D.L. The interaction profile of homologous recombination repair proteins RAD51C, RAD51D and XRCC2 as determined by proteomic analysis. Proteomics 2009, 9:4071-4086.